tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GNPX Stock Latest News

Genprex Gains Australian Patent Acceptance for REQORSA Therapy
Company AnnouncementsGenprex Gains Australian Patent Acceptance for REQORSA Therapy
6d ago
8K
GNPX
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
PremiumThe Fly
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
6d ago
GNPX
Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring
PremiumCompany Announcements
Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring
1M ago
8K
GNPX
Genprex advances GPX-002 diabetes gene therapy program
PremiumCompany Announcements
Genprex advances GPX-002 diabetes gene therapy program
1M ago
8K
GNPX
Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy
PremiumCompany Announcements
Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy
1M ago
8K
GNPX
Genprex reports ‘positive’ preclinical data from study of GPX-002
PremiumThe FlyGenprex reports ‘positive’ preclinical data from study of GPX-002
1M ago
GNPX
Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy
Premium
The Fly
Genprex publishes data from Acclaim-1 Phase 1 trial of Reqorsa Gene Therapy
3M ago
GNPX
Genprex Announces $75 Million Stock Offering
Premium
Company Announcements
Genprex Announces $75 Million Stock Offering
3M ago
8K
GNPX
Genprex files to sell 1.28M shares of common stock for holders
PremiumThe Fly
Genprex files to sell 1.28M shares of common stock for holders
3M ago
GNPX
Genprex Expands Clinical Trials with New Site Addition
PremiumCompany Announcements
Genprex Expands Clinical Trials with New Site Addition
3M ago
8K
GNPX
Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
PremiumThe Fly
Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
3M ago
AZN
GNPX
Genprex Secures U.S. Patent for Reqorsa® Therapy
PremiumCompany Announcements
Genprex Secures U.S. Patent for Reqorsa® Therapy
3M ago
8K
GNPX
Genprex granted U.S. patenet for Reqorsa Gene Therapy in cancer
PremiumThe FlyGenprex granted U.S. patenet for Reqorsa Gene Therapy in cancer
3M ago
GNPX
Genprex on path to receive European patent for Reqorsa in cancer
Premium
The Fly
Genprex on path to receive European patent for Reqorsa in cancer
3M ago
GNPX
Genprex Secures European Patent for Reqorsa® Therapy
Premium
Company Announcements
Genprex Secures European Patent for Reqorsa® Therapy
3M ago
8K
GNPX
Genprex Announces Securities Purchase Agreement and Offering
PremiumCompany Announcements
Genprex Announces Securities Purchase Agreement and Offering
4M ago
8K
GNPX
Genprex trading resumes
PremiumThe Fly
Genprex trading resumes
4M ago
GNPX
Genprex trading halted, volatility trading pause
PremiumThe Fly
Genprex trading halted, volatility trading pause
4M ago
GNPX
Genprex announces registered direct offering of up to $10M
PremiumThe Fly
Genprex announces registered direct offering of up to $10M
4M ago
GNPX
Genprex Announces Positive Preclinical Data for Reqorsa
PremiumCompany AnnouncementsGenprex Announces Positive Preclinical Data for Reqorsa
4M ago
8K
GNPX
Genprex presents positive preclinical data on Reqorsa Gene Therapy
Premium
The Fly
Genprex presents positive preclinical data on Reqorsa Gene Therapy
4M ago
GNPX
Genprex’s Innovative ES-SCLC Therapy: A Promising Clinical Update
Premium
Company Announcements
Genprex’s Innovative ES-SCLC Therapy: A Promising Clinical Update
4M ago
GNPX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >